Recruiting
Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma
Based on the bioholographic theory, this study preliminarily explores the clinical efficacy of hand acupuncture in treating acute exacerbation of bronchial asthma and evaluates its immediate anti-asthmatic effect, so as to provide a new therapeutic strategy for the clinical management of bronchial asthma.
ClinicalTrials.gov IDNCT07632352
PhaseNA
Enrollment72
SponsorHenan University of Traditional Chinese Medicine
Age18 Years
SexALL
Conditions studied
Bronchial Asthma
About this study
Based on the bioholographic theory, this study preliminarily explores the clinical efficacy of hand acupuncture in treating acute exacerbation of bronchial asthma and evaluates its immediate anti-asthmatic effect, so as to provide a new therapeutic strategy for the clinical management of bronchial asthma.
Interventions
- Other: Acupuncture — The acupoints selected were Kechuan point, New Kechuan point, and Yuji point. The treatment was administered once a day for 20 minutes each time, for 5 consecutive days.
- Drug: Standard Western medicine treatment — Evaluate and manage in accordance with the Chinese Expert Consensus on Assessment and Management of Acute Exacerbation of Bronchial Asthma issued by the Asthma Group of the Chinese Thoracic Society, Chinese Medical Association in 2018 and the Guidelines for the Prevention and Treatment of Bronchial Asthma (2020 ).
Primary outcomes
- Peak Expiratory Flow(PEF) (After treatment on Day 5 and follow-up at 1, 2 and 3 months)
- Asthma Control Test (After treatment on Day 5 and follow-up at 1, 2 and 3 months)
Eligibility information
Inclusion Criteria:
1. Patients meeting the Western medicine diagnostic criteria for acute exacerbation of bronchial asthma
2. Aged ≥ 18 years old
3. Voluntarily receive treatment and sign the informed consent form
Exclusion Criteria:
1. Those who fail to meet the inclusion criteria
2. Patients suffering from other severe systemic diseases such as diseases of the circulatory system, hematological system and nervous system
3. Pregnant or lactating women
4. Subjects enrolled but not treated per the study protocol
5. Patients who have participated in other clinical trials of medicinal products within 3 months
6. Other circumstances deemed ineligible for enrollment by researchers
Study locations
- the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.